BioCentury | May 25, 2018
Financial News

Aptinyx proposes $80M IPO

...2017) . On May 22, Aptinyx said Allergan plc (NYSE:AGN) exercised its option to acquire AGN-241751...
BioCentury | May 23, 2018
Financial News

Aptinyx proposes $80M IPO

...22, 2017) . On Tuesday, Aptinyx said Allergan plc (NYSE:AGN) exercised its option to acquire AGN-241751...
...small molecule NMDA receptor modulator in development to treat major depressive disorder. Chris Lieu NYX-2925 Allergan plc Aptinyx Inc. NMDA receptor Pain AGN-241751...
Items per page:
1 - 2 of 2